Evidence map›Paper›PMID 25656049›Full record

ArticleJournal of dermatological science2015

Gene expression profiling in pachyonychia congenita skin.

Yu-An Cao, Robyn P Hickerson, Brandon L Seegmiller, Dmitry Grapov, Maren M Gross, Marc R Bessette, Brett S Phinney, Manuel A Flores, Tycho J Speaker, Annaleen Vermeulen and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of dermatological science, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. The Epidermal Transcriptome Analysis of a Novel c.639_642dupInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Palmoplantar Keratoderma in Slurp2-Deficient Mice.The Journal of investigative dermatology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Yu-An CaoTransDerm Inc., Santa Cruz, CA 95060, USA.
Robyn P HickersonTransDerm Inc., Santa Cruz, CA 95060, USA.
Brandon L SeegmillerTransDerm Inc., Santa Cruz, CA 95060, USA.
Dmitry GrapovUniversity of California at Davis, Davis, CA 95616, USA.
Maren M GrossDharmacon part of GE Healthcare, Lafayette, CO 80026, USA.
Marc R BessetteDharmacon part of GE Healthcare, Lafayette, CO 80026, USA.
Brett S PhinneyUniversity of California at Davis, Davis, CA 95616, USA.
Manuel A FloresTransDerm Inc., Santa Cruz, CA 95060, USA.
Tycho J SpeakerTransDerm Inc., Santa Cruz, CA 95060, USA.
Annaleen VermeulenDharmacon part of GE Healthcare, Lafayette, CO 80026, USA.
Albert A BravoPodiatric Medicine and Surgery, Pittsfield, MA 01201, USA.
Anna L BrucknerUniversity of Colorado School of Medicine, Aurora, CO 80045, USA.
Leonard M MilstoneYale University, New Haven, CT 06520, USA.
Mary E SchwartzPachyonychia Congenita Project, Salt Lake City, UT 84109, USA.
Robert H RiceUniversity of California at Davis, Davis, CA 95616, USA.
Roger L KasparTransDerm Inc., Santa Cruz, CA 95060, USA. Electronic address: roger.kaspar@transderminc.com.
University of California, Davis · USPachyonychia Congenita Project · USUniversity of Colorado Denver · USYale University · US

Funding

Workshop on Environmental Technology Transfer and EntrepreneurshipP42ES004699 · NIEHS · UNIVERSITY OF CALIFORNIA DAVIS · PI HAMMOCK, BRUCE D · 1987 to 2021
$50.1M
West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Pachyonychia congenita clinical trial using therapeutic self-delivery siRNAsR44AR056559 · NIAMS · TRANSDERM, INC. · PI KASPAR, ROGER L · 2011 to 2013
$4.1M
Pachyonychia congenita clinical trial using therapeutic siRNAsR43AR056559 · NIAMS · TRANSDERM, INC. · PI KASPAR, ROGER L · 2008 to 2008
$313k
Development of topical formulations for delivery of next generation mTOR inhibitoR43AR065895 · NIAMS · TRANSDERM, INC. · PI KASPAR, ROGER L · 2014 to 2014
$225k
NIAMS NIH HHS R43 AR065895NIAMS NIH HHS R44 AR056559NIDDK NIH HHS U24 DK097154NIEHS NIH HHS P42 ES004699NIEHS NIH HHS P42 ES04699
6 · The paper itself

Abstract

backgroundPachyonychia congenita (PC) is a skin disorder resulting from mutations in keratin (K) proteins including K6a, K6b, K16, and K17. One of the major symptoms is painful plantar keratoderma. The pathogenic sequelae resulting from the keratin mutations remain unclear.

objectiveTo better understand PC pathogenesis.

methodsRNA profiling was performed on biopsies taken from PC-involved and uninvolved plantar skin of seven genotyped PC patients (two K6a, one K6b, three K16, and one K17) as well as from control volunteers. Protein profiling was generated from tape-stripping samples.

resultsA comparison of PC-involved skin biopsies to adjacent uninvolved plantar skin identified 112 differentially-expressed mRNAs common to patient groups harboring K6 (i.e., both K6a and K6b) and K16 mutations. Among these mRNAs, 25 encode structural proteins including keratins, small proline-rich and late cornified envelope proteins, 20 are related to metabolism and 16 encode proteases, peptidases, and their inhibitors including kallikrein-related peptidases (KLKs), and serine protease inhibitors (SERPINs). mRNAs were also identified to be differentially expressed only in K6 (81) or K16 (141) patient samples. Furthermore, 13 mRNAs were identified that may be involved in pain including nociception and neuropathy. Protein profiling, comparing three K6a plantar tape-stripping samples to non-PC controls, showed changes in the PC corneocytes similar, but not identical, to the mRNA analysis.

conclusionMany differentially-expressed genes identified in PC-involved skin encode components critical for skin barrier homeostasis including keratinocyte proliferation, differentiation, cornification, and desquamation. The profiling data provide a foundation for unraveling the pathogenesis of PC and identifying targets for developing effective PC therapeutics.

Indexed as

TranscriptomeDown-RegulationEnzymesGene Expression ProfilingHumansKeratin-16Keratin-17Keratin-6KeratinsOligonucleotide Array Sequence AnalysisPachyonychia CongenitaPainRNA, MessengerUp-RegulationEnzymesKeratin-16Keratin-17Keratin-6KeratinsRNA, MessengerDesquamationGenodermatosisKeratinocyteMonogenic skin disordermTOR signaling pathwayPainful palmoplantar keratoderma

Identifiers

PMID25656049
PMCPMC4374015
OpenAlexW2017384060

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.